adenine has been researched along with Diabetic Glomerulosclerosis in 20 studies
Excerpt | Relevance | Reference |
---|---|---|
" Here we show that GLP-1 analog, liraglutide, inhibits oxidative stress and albuminuria in streptozotocin (STZ)-induced type 1 diabetes mellitus rats, via a protein kinase A (PKA)-mediated inhibition of renal NAD(P)H oxidases." | 7.78 | GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases. ( Hendarto, H; Hirata, E; Ikeda, N; Inoguchi, T; Maeda, Y; Sonoda, N; Takayanagi, R; Takei, R; Yokomizo, H; Zheng, J, 2012) |
" Other types of renal disease frequently encountered during the late period include renal AA-amyloidosis and tenofovir-related kidney disease." | 3.79 | [Changing spectrum of renal disease in HIV infection]. ( Amann, K; Bickel, M; Brodt, HR; Geiger, H; Gröne, HJ; Grützmacher, P; Haack, HS; Jung, O, 2013) |
" Here we show that GLP-1 analog, liraglutide, inhibits oxidative stress and albuminuria in streptozotocin (STZ)-induced type 1 diabetes mellitus rats, via a protein kinase A (PKA)-mediated inhibition of renal NAD(P)H oxidases." | 3.78 | GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases. ( Hendarto, H; Hirata, E; Ikeda, N; Inoguchi, T; Maeda, Y; Sonoda, N; Takayanagi, R; Takei, R; Yokomizo, H; Zheng, J, 2012) |
" Most data on safety and efficacy in this scenario initially came from clinical trials in which tenofovir was combined with non-nucleoside reverse transcriptase inhibitors." | 2.44 | [Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors]. ( Fiorante, S; Pulido, F, 2008) |
" Chronic adenine dosing resulted in severe CKD in vehicle-treated rats as indicated by a marked rise in serum creatinine levels, a marked decrease in creatinine clearance, and a disturbed mineral metabolism." | 1.72 | Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats. ( Corremans, R; D'Haese, PC; De Broe, ME; Leysen, H; Maudsley, S; Neven, E; Verhulst, A; Vervaet, BA, 2022) |
"However, its functions in diabetic nephropathy (DN) have not been determined." | 1.62 | METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho. ( Deng, L; Li, M; Xu, G, 2021) |
"A 68-year-old man with type 2 diabetes mellitus and chronic hepatitis B infection was referred to the nephrology department before planned surgery for hepatocellular carcinoma." | 1.51 | Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency. ( Iino, N; Koda, R; Narita, I; Tsuchida, M, 2019) |
"Fibrinogen was correlated with urinary albumin excretion rates in men (r = 0." | 1.32 | Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. ( Clore, J; Garvey, WT; Hunter, SJ; Jenkins, AJ; Klein, RL; Semler, AJ; Zheng, D, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (20.00) | 29.6817 |
2010's | 10 (50.00) | 24.3611 |
2020's | 5 (25.00) | 2.80 |
Authors | Studies |
---|---|
Li, M | 1 |
Deng, L | 1 |
Xu, G | 1 |
Corremans, R | 1 |
Neven, E | 1 |
Maudsley, S | 1 |
Leysen, H | 1 |
De Broe, ME | 1 |
D'Haese, PC | 1 |
Vervaet, BA | 1 |
Verhulst, A | 1 |
Sharma, K | 1 |
Zhang, G | 1 |
Hansen, J | 1 |
Bjornstad, P | 1 |
Lee, HJ | 1 |
Menon, R | 1 |
Hejazi, L | 1 |
Liu, JJ | 1 |
Franzone, A | 1 |
Looker, HC | 1 |
Choi, BY | 1 |
Fernandez, R | 1 |
Venkatachalam, MA | 1 |
Kugathasan, L | 1 |
Sridhar, VS | 1 |
Natarajan, L | 1 |
Zhang, J | 1 |
Sharma, VS | 1 |
Kwan, B | 1 |
Waikar, SS | 1 |
Himmelfarb, J | 1 |
Tuttle, KR | 1 |
Kestenbaum, B | 1 |
Fuhrer, T | 1 |
Feldman, HI | 1 |
de Boer, IH | 1 |
Tucci, FC | 1 |
Sedor, J | 1 |
Heerspink, HL | 1 |
Schaub, J | 1 |
Otto, EA | 1 |
Hodgin, JB | 1 |
Kretzler, M | 1 |
Anderton, CR | 1 |
Alexandrov, T | 1 |
Cherney, D | 1 |
Lim, SC | 1 |
Nelson, RG | 1 |
Gelfond, J | 1 |
Iyengar, R | 1 |
Drexler, Y | 1 |
Fornoni, A | 1 |
Yasuda, H | 1 |
Tsukune, Y | 1 |
Inano, T | 1 |
Mori, Y | 1 |
Ota, Y | 1 |
Komatsu, N | 1 |
Fan, Z | 1 |
Wang, Y | 1 |
Xu, X | 1 |
Wu, Y | 1 |
Singh, L | 1 |
Arya, A | 1 |
Gupta, S | 1 |
Koda, R | 1 |
Tsuchida, M | 1 |
Iino, N | 1 |
Narita, I | 1 |
Fang, L | 2 |
Zhou, Y | 1 |
Cao, H | 1 |
Wen, P | 1 |
Jiang, L | 1 |
He, W | 2 |
Dai, C | 2 |
Yang, J | 2 |
Jung, O | 1 |
Haack, HS | 1 |
Brodt, HR | 1 |
Grützmacher, P | 1 |
Geiger, H | 1 |
Amann, K | 1 |
Gröne, HJ | 1 |
Bickel, M | 1 |
Wang, B | 1 |
Jha, JC | 1 |
Hagiwara, S | 1 |
McClelland, AD | 1 |
Jandeleit-Dahm, K | 1 |
Thomas, MC | 1 |
Cooper, ME | 1 |
Kantharidis, P | 1 |
Li, X | 1 |
Luo, Y | 1 |
Liu, J | 1 |
Li, QX | 1 |
Wang, XJ | 1 |
Zhang, C | 1 |
Duan, YQ | 1 |
Wang, ZY | 1 |
Zhang, Y | 1 |
Yu, X | 1 |
Li, NJ | 1 |
Sun, JP | 1 |
Yi, F | 1 |
Du, Y | 1 |
Li, YJ | 1 |
Hu, XX | 1 |
Deng, X | 1 |
Qian, ZT | 1 |
Li, Z | 1 |
Guo, MZ | 1 |
Tang, DQ | 1 |
Pulido, F | 1 |
Fiorante, S | 1 |
Hendarto, H | 1 |
Inoguchi, T | 1 |
Maeda, Y | 1 |
Ikeda, N | 1 |
Zheng, J | 1 |
Takei, R | 1 |
Yokomizo, H | 1 |
Hirata, E | 1 |
Sonoda, N | 1 |
Takayanagi, R | 1 |
Klein, RL | 1 |
Hunter, SJ | 1 |
Jenkins, AJ | 1 |
Zheng, D | 1 |
Semler, AJ | 1 |
Clore, J | 1 |
Garvey, WT | 1 |
Di Biagio, A | 1 |
Bassetti, M | 1 |
Briozzo, A | 1 |
Ferrazin, A | 1 |
Rosso, R | 1 |
Gatti, G | 1 |
Cruciani, M | 1 |
Bassetti, D | 1 |
Fine, DM | 1 |
Perazella, MA | 1 |
Lucas, GM | 1 |
Atta, MG | 1 |
Kunjara, S | 1 |
Beardsley, SJ | 1 |
Greenbaum, AL | 1 |
2 reviews available for adenine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
[Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors].
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cohort St | 2008 |
Kidney biopsy in HIV: beyond HIV-associated nephropathy.
Topics: Acute Disease; Adenine; AIDS-Associated Nephropathy; Anti-HIV Agents; Antiretroviral Therapy, Highly | 2008 |
18 other studies available for adenine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho.
Topics: Adenine; Animals; Biomarkers; Blood Glucose; Cells, Cultured; Diabetic Nephropathies; Disease Models | 2021 |
Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats.
Topics: Adenine; Animals; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; | 2022 |
Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients.
Topics: Adenine; Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic N | 2023 |
Adenine crosses the biomarker bridge: from 'omics to treatment in diabetic kidney disease.
Topics: Adenine; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Kidney Failu | 2023 |
Successful Long-Term Ibrutinib Treatment in a Hemodialysis Patient With Leukemic Nonnodal Mantle Cell Lymphoma.
Topics: Adenine; Aged; Diabetic Nephropathies; Humans; Lymphoma, Mantle-Cell; Male; Piperidines; Renal Dialy | 2021 |
Inhibitor of Bruton's tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators' production in high glucose-induced macrophages.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Anti-Inflammatory Agents; Bone Marrow Cells; | 2018 |
Role of atrial natriuretic peptide in controlling diabetic nephropathy in rats.
Topics: Adenine; Animals; Atrial Natriuretic Factor; Blood Glucose; Diabetes Mellitus, Experimental; Diabeti | 2018 |
Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency.
Topics: Adenine; Aged; Antiviral Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnostic Error | 2019 |
Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia-induced podocyte injury.
Topics: Adenine; Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Diabetic Nephropathies; Endopl | 2013 |
[Changing spectrum of renal disease in HIV infection].
Topics: Adenine; Adult; AIDS-Associated Nephropathy; Amyloidosis; Anti-HIV Agents; Antiretroviral Therapy, H | 2013 |
Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Topics: 3' Untranslated Regions; Adenine; Animals; Apolipoproteins E; Binding Sites; Cell Line; Diabetic Nep | 2014 |
Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress.
Topics: Adenine; Adult; Animals; Apoptosis; Autophagy; Blotting, Western; Case-Control Studies; Cells, Cultu | 2014 |
β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.
Topics: Adenine; Animals; Apoptosis; Autophagy; Autophagy-Related Proteins; beta-Arrestins; Cells, Cultured; | 2016 |
Development and evaluation of a hydrophilic interaction liquid chromatography-MS/MS method to quantify 19 nucleobases and nucleosides in rat plasma.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenine; Animals; Chromatography, Liquid; Chromatography, Reverse-Phase | 2017 |
GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Topics: Adenine; Albuminuria; Animals; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Diabetes Melli | 2012 |
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
Topics: Adenine; Adult; Albuminuria; Base Sequence; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 1; D | 2003 |
Tenofovir use in a patient with a severe renal impairment.
Topics: Adenine; Adult; Diabetic Nephropathies; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV I | 2004 |
Renal hypertrophy in experimental diabetes. The activity of the 'de novo' and salvage pathways of purine [corrected] synthesis.
Topics: Adenine; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA; Formates; Hypertroph | 1988 |